TickerTain
TickerTain
NewsroomShortsPortfolioConvergence
NewsroomShortsPortfolioConvergence
←
▶ 1:00 · Family-Controlled Companies & Long-Term Ownership · Elkann: Family control plus public markets creates optimal stability and long-term thinking
episode briefing
In Good Company with Nicolai Tangen

John Elkann - CEO of Exor | Podcast | In Good Company | Norges Bank Investment Management

2024-06-19 · 6 company · 5 thematic
sentiment
5 bull0 bear1 neu
speakers
john elkann

CEO of Exor, the Dutch-Italian holding company controlling Ferrari, Stellantis, Juventus, CNH Industrial, Iveco, and a major stake in Philips; joined board at 21, led group through near-bankruptcy to stability and growth.

now playing · Family-Controlled Companies & Long-Term Ownership
Family-Controlled Companies & Long-Term Ownershiptailwindscore 8/10john elkann
Elkann: Family control plus public markets creates optimal stability and long-term thinking
Committed family ownership provides stability and multi-decade horizons while public listing adds market discipline; Exor models itself on Berkshire Hathaway and Investor AB as a permanent…
Chinese EV Market Dominancetailwindscore 7/10john elkann
China produces and sells over two-thirds of global EVs — Western OEMs must partner or lose
China's EV ecosystem dominance (2/3 of sales and production) forces Western automakers like Stellantis to form partnerships (Leap Motors) to access technology, cost structure, and market sh…
EV Transition & Battery Supply Chaintailwindscore 7/10john elkann
Stellantis pursues EV cost parity via controlled battery supply (ACC JV) and Chinese tech partnership
Winning in EVs requires owning battery supply — Stellantis built ACC with TotalEnergies/Mercedes in Europe and partnered with LG/Samsung in North America, while Leap Motors gives China mark…
European Competitiveness in Batteriesmixedscore 6/10john elkann
Elkann: Europe must compete in battery chemistry and assembly to secure EV supply chain
Batteries are the most expensive EV component; Europe needs cost-competitive domestic cell production (ACC in Germany/France/Italy) plus partnerships with Asian leaders (LG, Samsung) to avo…
Healthcare Technologytailwindscore 8/10john elkann
Exor bets on Philips as healthcare technology enabler solving structural cost crisis
Post-pandemic awareness of healthcare fragility and rising costs drives Exor to invest in enablers like Philips, which combines deep history with renewed health-tech focus and ambitious lea…